Compounds > pramipexole
Page last updated: 2024-09-03

pramipexole and cytochrome c-t

pramipexole has been researched along with cytochrome c-t in 4 studies

Compound Research Comparison

Studies
(pramipexole)		Trials
(pramipexole)		Recent Studies (post-2010)
(pramipexole)		Studies
(cytochrome c-t)		Trials
(cytochrome c-t)		Recent Studies (post-2010) (cytochrome c-t)
1,10321951711,809215,125

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooper, JM; Gu, M; Iravani, MM; Irvani, M; Jenner, P; King, D; Schapira, AH1
Ali, N; Fujita, Y; Hamano, S; Izawa, Y; Kanematsu, Y; Tamaki, T; Tsuchiya, K; Yoshizumi, M1
Ariga, H; Inden, M; Kitamura, Y; Shibaike, T; Taira, T; Takata, K; Tamaki, A; Taniguchi, T; Yamamoto, A; Yanagida, T; Yasui, H1
Ali, M; Andrabi, SS; Parveen, S; Parvez, S; Tabassum, H1

Other Studies

4 other study(ies) available for pramipexole and cytochrome c-t

ArticleYear
Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms.
    Journal of neurochemistry, 2004, Volume: 91, Issue:5

    Topics: 1-Methyl-4-phenylpyridinium; Aconitate Hydratase; Antioxidants; Benzothiazoles; Carbocyanines; Caspase 3; Caspases; Cell Count; Cell Death; Cell Line, Tumor; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Drug Interactions; Flow Cytometry; Humans; Jurkat Cells; L-Lactate Dehydrogenase; Mitochondria; Necrosis; Neuroblastoma; Pramipexole; Rotenone; Thiazoles

2004
Pramipexole protects against H2O2-induced PC12 cell death.
    Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 372, Issue:4

    Topics: Animals; Antiparkinson Agents; Apoptosis; Benzothiazoles; Caspase 3; Caspases; Cell Death; Cell Survival; Cytochromes c; Dopamine Agonists; Dopamine Antagonists; Hydrogen Peroxide; L-Lactate Dehydrogenase; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Pramipexole; Rats; Thiazoles

2006
Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Neurochemistry international, 2009, Volume: 55, Issue:8

    Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Apoptosis; Benzothiazoles; Cell Line, Tumor; Corpus Striatum; Cytochromes c; Dopamine; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Hydroxyl Radical; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neural Pathways; Neurotoxins; Oxidative Stress; Parkinsonian Disorders; Pramipexole; Proto-Oncogene Proteins c-bcl-2; Rotenone; Substantia Nigra; Uncoupling Agents

2009
Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke.
    Disease models & mechanisms, 2019, 08-29, Volume: 12, Issue:8

    Topics: Animals; bcl-2-Associated X Protein; Brain Ischemia; Calcium; Cell Death; Cytochromes c; Down-Regulation; Energy Metabolism; Hand Strength; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Swelling; Motor Activity; Oxygen Consumption; Pramipexole; Rats, Wistar; Reactive Oxygen Species; Recovery of Function; Signal Transduction; Stroke

2019